ArriVent BioPharma, Inc. Common Stock
AVBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $838 | $639 | $670 | $26 |
| - Cash | $74 | $150 | $163 | $37 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $764 | $489 | $507 | -$12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$80 | -$75 | $0 | -$52 |
| % Margin | – | – | – | – |
| Net Income | -$80 | -$69 | -$37 | -$52 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.56 | -2.17 | -1.1 | -40.44 |
| % Growth | -18% | -97.3% | 97.3% | – |
| Operating Cash Flow | -$70 | -$56 | -$44 | -$13 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$70 | -$56 | -$44 | -$13 |